Nifty Midcap Index News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nifty midcap index. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nifty Midcap Index Today - Breaking & Trending Today

How large-cap stocks can offer a buffer against heightened volatility?

In the past two months, FIIs have been selling ahead of the upcoming election results, while retail investors remain cautious with a bias on investing in mid and small-cap stocks. ....

Vinod Nair , Head Of Research , Geojit Financial Services , Nifty Midcap Index , Geojit Financial ,

Nifty LargeMidcap Index for a blend of stability and high returns

Nifty 100 ranks high for 3 and 5 years, offering lower risk-adjusted returns. Nifty Mid and Small indices rank low, with Midcap index providing higher returns but also higher risk. Nifty LargeMidcap 250 index consistently ranks 2nd, offering high risk-adjusted returns. ....

Nifty Largemidcap , Questions Answered , Nifty Midcap , Nifty Large Midcap , Nifty Smallcap , Mutual Funds , Nifty Mid , Personal Finance , Index Funds , Expert Speak , Nifty Largemidcap 250 Index , Nifty Large Midcap 250 Index Fund , Equity Funds , Nifty Mid And Small Indices , Nifty Smallcap Index , Nifty Midcap Index ,

pharma stocks: Pramod Amthe is selective in midcaps; betting on 4 pharma stocks

The better way to play pharma is Sun Pharma and Aurobindo which we like. The other trend is domestic outlook for the growth for pharma. The proxy there is Torrent and Ajanta.Railways have new avenues of growth and strong momentum. Medium-term targets and government support improve growth prospects. Larger railway stocks like Concor, Kalpataru, and KEC are attractive due to their involvement in electrification lines. Having said that, some of the mid and smallcaps have run up much sharper. ....

Uttar Pradesh , Sun Pharma , Pramod Amthe , Offering College , Head Of Institutional Equity Research , Indian School Of Business , Ashok Leyland , Institutional Equity Research , Incred Capital , Orchid Pharma , Leadership Excellence , Product Officer , Executive Officer , Might Also Like , Nifty Midcap Index , Data Patterns , Bharat Forge , Mahindra Finance , Pharma Stocks , Private Banks , Defence Related Areas , Expert View , Stock Market , Et Now ,